Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1PLOS PATHOGENSIF4.92024-07-112OAAI
Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases COMMENTNATURE REVIEWS DRUG DISCOVERYIF101.82021-09-011OA
Surmounting structural barriers to tackle endemic infectious diseasesJOURNAL OF EXPERIMENTAL MEDICINEIF10.62021-08-191OAAI
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial ActivityACS MEDICINAL CHEMISTRY LETTERSIF42021-08-1610OAAI
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial多种无偏方法将氧化鲨烯环化酶鉴定为有希望的抗利什曼原药的分子靶标CELL CHEMICAL BIOLOGYIF7.22021-05-0114OAAI
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T.b. brucei hitcompound with improved pharmacokinetic propertiesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92020-11-0113OAAI
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92020-09-0116OAAI
Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA SynthetaseACS INFECTIOUS DISEASESIF3.82020-04-1013OAAI
New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruziACS MEDICINAL CHEMISTRY LETTERSIF42020-02-0610OAAI
The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovaniACS INFECTIOUS DISEASESIF3.82020-01-2224OAAI
Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and LeishmaniasisCURRENT MEDICINAL CHEMISTRYIF3.52019-10-1048OA
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12019-04-08115OAAI
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12019-03-20111OAAI
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial ActivityACS MEDICINAL CHEMISTRY LETTERSIF42018-12-1936OAAI
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovaniACS INFECTIOUS DISEASESIF3.82018-11-0153OAAI
Development of Chemical Proteomics for the Folateome and Analysis of the Kinetoplastid FolateomeACS INFECTIOUS DISEASESIF3.82018-09-282OAAI
Antitrypanosomatid Pharmacomodulation at Position 3 of the 8-Nitroquinolin-2(1H)-one Scaffold Using Palladium-Catalysed Cross-Coupling ReactionsCHEMMEDCHEMIF3.42018-09-178OAAI
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need (vol 15, pg 217, 2017)NATURE REVIEWS MICROBIOLOGYIF103.32018-09-111OAAI
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a] pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92018-09-0116OAAI